作者
Antonia F. Stepan,Chakrapani Subramanyam,Ivan Efremov,Jason K. Dutra,Theresa J. O’Sullivan,Kenneth J. DiRico,W. Scott McDonald,Annie Won,Peter H. Dorff,Charles E. Nolan,Stacey L. Becker,Leslie R. Pustilnik,David Riddell,Gregory W. Kauffman,Bethany L. Kormos,Liming Zhang,Yasong Lu,S.H. Capetta,Michael E. Green,Kapil Karki,E. Sibley,Kevin Atchison,A.J. Hallgren,Christine Oborski,Ashley Robshaw,Blossom Sneed,Christopher J. O’Donnell
摘要
Replacement of the central, para-substituted fluorophenyl ring in the γ-secretase inhibitor 1 (BMS-708,163) withthe bicyclo[1.1.1]pentane motif led to the discovery of compound 3, an equipotent enzyme inhibitor with significant improvements in passive permeability and aqueous solubility. The modified biopharmaceutical properties of 3 translated into excellent oral absorption characteristics (∼4-fold ↑ Cmax and AUC values relative to 1) in a mouse model of γ-secretase inhibition. In addition, SAR studies into other fluorophenyl replacements indicate the intrinsic advantages of the bicyclo[1.1.1]pentane moiety over conventional phenyl ring replacements with respect to achieving an optimal balance of properties (e.g., γ-secretase inhibition, aqueous solubility/permeability, in vitro metabolic stability). Overall, this work enhances the scope of the [1.1.1]-bicycle beyond that of a mere “spacer” unit and presents a compelling case for its broader application as a phenyl group replacement in scenarios where the aromatic ring count impacts physicochemical parameters and overall drug-likeness.